To validate the hypothesis, we transfected si-FGF9 into T24 cells to generate FGF9 knockdown T24 bladder cancer cells, and performed real-time PCR (Figure 2A) and immunoblotting (Figure 2E) to verify the transfection efficiency. Here, FGF9 is linked to urinary bladder carcinoma.